Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2021-08-24 00:00:00 ET · period of report 2021-08-23 · accession 0001209191-21-053237 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-24 | 2021-08-23 | VIR | Rice Steven J. | Chief Administrative Off | M - OptEx | $12.76 | +10.0K | 30.0K | +50% | +$127.6K |
| D | 2021-08-24 | 2021-08-23 | VIR | Rice Steven J. | Chief Administrative Off | S - Sale+OE | $50.00 | -10.0K | 20.0K | -33% | -$500.0K |
| D | 2021-08-24 | 2021-08-23 | VIR | Rice Steven J. | Chief Administrative Off | M - OptEx | $0.00 | -10.0K | 434.4K | -2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-23 | M | A | 10,000 | $12.76 | 30,000 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-23 | S | D | 10,000 | $50.00 | 20,000 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2021-08-23 | M | D | 10,000 | $0.00 | 434,441 | D | $12.76 · — to 2029-12-10 | 10,000 Common Stock | (F2) 1/4 of the shares subject to the stock option vest and become exercisable on September 15, 2020, and the remainder vest in 36 equal monthly installments thereafter. |